Investigação sobre o uso do ácido retinoico a 3% e a 5% em soluções para peeling como agente para drug delivery após indução percutânea de colágeno com agulhas (IPCA®): perfil de segurança e protocolo de uso

Lima, Emerson de Andrade; Lima, Mariana de Andrade; Araújo, Cláudio Eduardo Cavalcante de; Nakasawa, Yara Maria Maia; Leal, Nilma Cintra

doi:10.5935/scd1984-8773.201810104

0
View

Open Access

Peer-Reviewed
Artigo Original

Investigation on the use of 3% and 5% retinoic acid in peeling solutions as a drug delivery agent after percutaneous induction of collagen with needles (IPCA^®): safety profile and application protocol

Emerson de Andrade Lima¹; Mariana de Andrade Lima¹; Cláudio Eduardo Cavalcante de Araújo^2,3; Yara Maria Maia Nakasawa^2,3; Nilma Cintra Leal^2,3

DOI: https://doi.org/10.5935/scd1984-8773.201810104

Send this article by email

Read in Portuguese
Portuguese PDF
PDF
Send this article by email
How to cite this article
Submit a comment
Mendeley
Pocket
Share on Facebook
Share on Twitter

All content the journal, except where identified, is under a Creative Commons Attribution-NonCommercial 4.0 International license - ISSN-e 1984-8773

Investigation on the use of 3% and 5% retinoic acid in peeling solutions as a drug delivery agent after percutaneous induction of collagen with needles (IPCA®): safety profile and application protocol

Send this article by email

Investigation on the use of 3% and 5% retinoic acid in peeling solutions as a drug delivery agent after percutaneous induction of collagen with needles (IPCA^®): safety profile and application protocol